-+ 0.00%
-+ 0.00%
-+ 0.00%

WBB Securities Reiterates Strong Buy on Marker Therapeutics, Maintains $12.5 Price Target

Benzinga·04/01/2025 10:09:45
Listen to the news
WBB Securities analyst Steve Brozak reiterates Marker Therapeutics (NASDAQ:MRKR) with a Strong Buy and maintains $12.5 price target.